NAD (sodium)

• UNSPSC Description:

  NAD (β-Nicotinamide Adenine Dinucleotide) sodium is an analogue of NAD. NAD sodium can be reduced to β-nicotinamide adenine dinucleotide (NADH) during coupling with reactions which oxidize organic substrates. NAD sodium can be converted to β-nicotinamide adenine dinucleotide (NADH) and passes to the inside of mitochondria that indirectly generates ATP[1].

• Target Antigen:

  Endogenous Metabolite

• Type:

  Biochemical Assay Reagents

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Metabolism-protein/nucleotide metabolism

• Field of Research:

  Metabolic Disease

• Assay Protocol:

  https://www.medchemexpress.com/nad-sodium.html

• Purity:

  99.07

• Solubility:

  DMSO : 25 mg/mL (ultrasonic;warming;heat to 60°C)|H2O : 125 mg/mL (ultrasonic)

• Smiles:

  O[C@H]1[C@@H](O)[C@H]([N+]2=CC=CC(C(N)=O)=C2)O[C@@H]1COP([O-])(OP(OC[C@@H]3[C@@H](O)[C@@H](O)[C@H](N4C5=NC=NC(N)=C5N=C4)O3)(O[Na])=O)=O

• Molecular Weight:

  685.41

• References & Citations:

  [1]Bartlett P.N, et, al. The oxidation of β-nicotinamide adenine dinucleotide (NADH) at poly(aniline)-coated electrodes: Part II. Kinetics of reaction at poly(aniline)–poly(styrenesulfonate) composites. 2022 May 22;486(1):23-31.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -20°C (Powder, sealed storage, away from moisture)

• Clinical Information:

  Phase 2

• CAS Number:

  20111-18-6